The 8 analysts offering 12-month price forecasts for Rhythm Pharmaceuticals Inc have a median target of 36.00, with a high estimate of 43.00 and a low estimate of 18.00. The median estimate represents a +75.18% increase from the last price of 20.55.
The current consensus among 8 polled investment analysts is to Buy stock in Rhythm Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.88
Reporting Date Mar 16
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.